Volatility
₹10,000 per month in PPF or SIP? Which builds more wealth in 15 years - A comparison of post-tax return
Rima invests in PPF, while Seema opts for an equity SIP. Rima's corpus may reach ₹32.5 lakh after 15 years, tax-free. Seema’s final amount fluctuates based on market returns, potentially achieving up to ₹46 lakh after tax, highlighting differing investment risk and reward dynamics.
2 min read29 Aug 2026Want higher returns without taking much more risk? Add equity, then gold
A study by WhiteOak Capital Mutual Fund reveals that diversification improves risk-adjusted returns. It shows that including a small equity allocation in a debt portfolio can enhance returns and lower volatility
3 min read25 Aug 2026Starting to invest at 25? 4 simple steps to build your financial roadmap
Rony, a 25-year-old first-time earner with low risk tolerance, is overwhelmed by investing. A structured four-step formula can guide him: maintain liquid funds for emergencies, prioritise insurance, allocate investments based on timelines, and track real returns to make informed decisions.
2 min read8 Aug 2026What India's investors can learn from South Korea's market meltdown
South Korea's AI-driven stock market boom turned into a sharp rout within weeks. Here's what Indian investors can learn about leverage, passive investing, diversification and FOMO.
6 min read5 Aug 2026The best way to navigate market volatility? Invest for milestones, not markets
Market volatility often fuels fear and greed, prompting costly investment mistakes. Goal-based investing shifts the focus from market moves to life milestones, helping investors stay disciplined.
3 min read28 Jul 2026Don't overpay for growth: Nippon Life AMC's Sailesh Raj Bhan on navigating India's next market cycle
After two years of valuation-led consolidation, Nippon Life AMC's equity CIO Sailesh Raj Bhan says improving earnings, reasonable valuations and a strong macro backdrop are creating fresh opportunities for long-term investors.
5 min read17 Jul 2026Nifty Pharma jumps 14% YTD, outshines Nifty 50; is there more upside ahead?
The Nifty Pharma index has surged 14.53% YTD, outperforming the Nifty 50's 7.87% decline. Key drivers include improving earnings visibility and stable demand in domestic formulations, while geopolitical tensions and inflation concerns weigh on broader market sentiment.
4 min read15 Jul 2026Markets tumble after Donald Trump ends ceasefire
The Nifty 50 fell 2.1% to 23,882, while the Sensex fell 2.1% to 76,503—their lowest levels since 30 March.
2 min read8 Jul 2026Raja Venkatraman recommends three stocks for 30 June
Market expert Raja Venkatraman shares his top stock picks for 30 June. Here’s his technical outlook and trade strategy.
6 min read30 Jun 2026What should SIP investors do amid market volatility? From diversification to allocation — Here's what experts said
Amid market volatility, we asked experts what SIP investors can do to protect their portfolio. From emphasising continuance and review of portfolio to diversifying asset allocation — here's their advice…
4 min read28 Jun 2026Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.